Drug Type Chemical drugs |
Synonyms CVL608 |
Target |
Action inhibitors |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | China | 15 Aug 2020 | |
Breast Cancer | Preclinical | China | 15 Aug 2020 | |
Melanoma | Preclinical | China | 15 Aug 2020 | |
Melanoma | Preclinical | China | 15 Aug 2020 | |
Multiple Myeloma | Preclinical | China | 15 Aug 2020 | |
Multiple Myeloma | Preclinical | China | 15 Aug 2020 | |
Non-Small Cell Lung Cancer | Preclinical | China | 15 Aug 2020 | |
Non-Small Cell Lung Cancer | Preclinical | China | 15 Aug 2020 |